Modulation of Anthracycline-Induced Cardiotoxicity by Aerobic Exercise in Breast Cancer Current Evidence and Underlying Mechanisms

被引：128
|
作者：
Scott, Jessica M. [1 ]
Khakoo, Aarif [2 ]
Mackey, John R. [3 ]
Haykowsky, Mark J. [3 ]
Douglas, Pamela S. [4 ]
Jones, Lee W. [4 ]
机构：
[1] NASA, Lyndon B Johnson Space Ctr, Univ Space Res Assoc, Houston, TX 77058 USA
[2] Univ Texas MD, Amgen Inc, San Francisco, CA USA
[3] Univ Alberta, Edmonton, AB, Canada
[4] Duke Univ, Med Ctr, Durham, NC USA
来源：
CIRCULATION | 2011年 / 124卷 / 05期
基金：
加拿大自然科学与工程研究理事会; 美国国家卫生研究院;
关键词：
cardioprotection; cardiotoxicity; exercise; women; MUSCLE MALONYL-COA; SKELETAL-MUSCLE; HEART-FAILURE; VOLUNTARY EXERCISE; DOXORUBICIN CARDIOTOXICITY; INTENSITY EXERCISE; PHYSICAL-EXERCISE; CARDIAC TOXICITY; PROTECTS; APOPTOSIS;
D O I：
10.1161/CIRCULATIONAHA.111.021774
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：642 / 650
页数：9
相关论文
共 50 条
  • [31] Risk and cost of anthracycline-induced cardiotoxicity among breast cancer patients in the United States
    Choi, J. C.
    Chang, J. D.
    Seal, B.
    Tangirala, M.
    Mullins, C. D.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [32] Incidence of anthracycline-induced cardiotoxicity in patients with breast cancer: A single center's experience
    Nadeem, O.
    Rauwerdink, C.
    Beggs, V. L.
    Parr, D. D.
    Kono, A. T.
    Schwartz, G. N.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [33] Risk Factors for Anthracycline-Induced Cardiotoxicity in Breast Cancer Treatment: A Meta-Analysis
    Zhang, Meilin
    Yang, Hongguang
    Xu, Changcun
    Jin, Feng
    Zheng, Ang
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [34] Systems genetics approach identifies the genetic basis underlying anthracycline-induced cardiotoxicity
    Orgil, Buyan-Ochir
    Alberson, Neely
    Bajpai, Akhilesh
    Lander, Morgan
    Lu, Lu
    Towbin, Jeffrey
    Purevjav, Enkhsaikhan
    CIRCULATION RESEARCH, 2024, 135
  • [35] Anthracycline-induced cardiotoxicity in children with cancer: Strategies for prevention and management
    Iarussi D.
    Indolfi P.
    Casale F.
    Martino V.
    Di Tullio M.T.
    Calabrò R.
    Pediatric Drugs, 2005, 7 (2) : 67 - 76
  • [36] Anthracycline-induced cardiotoxicity in cancer patients: The scope of the problem - Introduction
    Lipshultz, Steven E.
    SEMINARS IN ONCOLOGY, 2006, 33 (03) : S1 - S1
  • [37] Anthracycline-Induced Cardiotoxicity in Young Cancer Patients: The Role of Carnitine
    Armenian, Saro H.
    ANNALS OF NUTRITION AND METABOLISM, 2016, 68 : 10 - 14
  • [38] Prevention of Anthracycline-Induced Cardiotoxicity: The Good and Bad of Current and Alternative Therapies
    Sangweni, Nonhlakanipho F.
    van Vuuren, Derick
    Mabasa, Lawrence
    Gabuza, Kwazi
    Huisamen, Barbara
    Naidoo, Sharnay
    Barry, Reenen
    Johnson, Rabia
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [39] Comparison of cardiovascular risk scores to predict anthracycline-induced cardiotoxicity in early breast cancer patients
    Solfanelli, Giorgio
    Bianchini, Giulia
    Petrungaro, Mattia
    Reale, Simone
    Lanza, Oreste
    Ferrera, Armando
    Tini, Giacomo
    Piras, Marta
    Pellegrini, Patrizia
    Tocci, Giuliano
    Battistoni, Allegra
    Volpe, Massimo
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2021, 23 (SUPPL G)
  • [40] microRNAs associated to anthracycline-induced cardiotoxicity in women with breast cancer: A systematic review and pathway analysis
    Pereira, Jessica Diniz
    Goncalves Tosatti, Jessica Abdo
    Simoes, Ricardo
    Luizon, Marcelo Rizzatti
    Gomes, Karina Braga
    Alves, Michelle Teodoro
    BIOMEDICINE & PHARMACOTHERAPY, 2020, 131
12345